Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

The complex existence of γδ T cells following transplantation: the good, the bad and the simply confusing.

Sullivan LC, Shaw EM, Stankovic S, Snell GI, Brooks AG, Westall GP.

Clin Transl Immunology. 2019 Sep 17;8(9):e1078. doi: 10.1002/cti2.1078. eCollection 2019. Review.

2.

Transfer of donor anti-HLA antibody expression to multiple transplant recipients: A potential variant of the passenger lymphocyte syndrome?

Kummrow M, Hiho S, Hudson F, Cantwell L, Mulley WR, D'Orsogna L, Testro A, Pavlovic J, MacDonald P, Sullivan LC, Snell GI, Westall GP.

Am J Transplant. 2019 May;19(5):1577-1581. doi: 10.1111/ajt.15262. Epub 2019 Feb 13.

PMID:
30653828
3.

Multiple receptors converge on H2-Q10 to regulate NK and γδT-cell development.

Goodall KJ, Nguyen A, Matsumoto A, McMullen JR, Eckle SB, Bertolino P, Sullivan LC, Andrews DM.

Immunol Cell Biol. 2019 Mar;97(3):326-339. doi: 10.1111/imcb.12222. Epub 2019 Jan 13.

PMID:
30537346
4.

Enrichment of Cytomegalovirus-induced NKG2C+ Natural Killer Cells in the Lung Allograft.

Harpur CM, Stankovic S, Kanagarajah A, Widjaja JML, Levvey BJ, Cristiano Y, Snell GI, Brooks AG, Westall GP, Sullivan LC.

Transplantation. 2019 Aug;103(8):1689-1699. doi: 10.1097/TP.0000000000002545.

PMID:
30461721
5.

Modulation of NKG2D, NKp46, and Ly49C/I facilitates natural killer cell-mediated control of lung cancer.

Shi L, Li K, Guo Y, Banerjee A, Wang Q, Lorenz UM, Parlak M, Sullivan LC, Onyema OO, Arefanian S, Stelow EB, Brautigan DL, Bullock TNJ, Brown MG, Krupnick AS.

Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):11808-11813. doi: 10.1073/pnas.1804931115. Epub 2018 Oct 31.

6.

HLA class II Eplet mismatch predicts De Novo DSA formation post lung transplant.

Walton DC, Cantwell L, Hiho S, Ta J, Wright S, Sullivan LC, Snell GI, Westall GP.

Transpl Immunol. 2018 Dec;51:73-75. doi: 10.1016/j.trim.2018.10.002. Epub 2018 Oct 12.

PMID:
30321645
7.

γδ T Cells in Transplantation: Friend and Foe.

Sullivan LC, Shaw EM, Westall GP.

Transplantation. 2018 Dec;102(12):1970-1971. doi: 10.1097/TP.0000000000002336. No abstract available.

PMID:
29994979
8.

Activating KIR Haplotype Influences Clinical Outcome Following HLA-Matched Sibling Hematopoietic Stem Cell Transplantation.

Heatley SL, Mullighan CG, Doherty K, Danner S, O'Connor GM, Hahn U, Szer J, Schwarer A, Bradstock K, Sullivan LC, Bardy PG, Brooks AG.

HLA. 2018 Jun 25. doi: 10.1111/tan.13327. [Epub ahead of print]

PMID:
29943500
9.

The expanding role of murine class Ib MHC in the development and activation of Natural Killer cells.

Goodall KJ, Nguyen A, Sullivan LC, Andrews DM.

Mol Immunol. 2018 May 19. pii: S0161-5890(18)30146-9. doi: 10.1016/j.molimm.2018.05.001. [Epub ahead of print] Review.

PMID:
29789149
10.

A conserved energetic footprint underpins recognition of human leukocyte antigen-E by two distinct αβ T cell receptors.

Sullivan LC, Walpole NG, Farenc C, Pietra G, Sum MJW, Clements CS, Lee EJ, Beddoe T, Falco M, Mingari MC, Moretta L, Gras S, Rossjohn J, Brooks AG.

J Biol Chem. 2017 Dec 22;292(51):21149-21158. doi: 10.1074/jbc.M117.807719. Epub 2017 Sep 25.

11.

Stretch activation properties of Drosophila and Lethocerus indirect flight muscle suggest similar calcium-dependent mechanisms.

Glasheen BM, Eldred CC, Sullivan LC, Zhao C, Reedy MK, Edwards RJ, Swank DM.

Am J Physiol Cell Physiol. 2017 Dec 1;313(6):C621-C631. doi: 10.1152/ajpcell.00110.2017. Epub 2017 Aug 23.

12.

Structure-function relationships of protein-lipopeptide complexes and influence on immunogenicity.

Wijayadikusumah AR, Sullivan LC, Jackson DC, Chua BY.

Amino Acids. 2017 Oct;49(10):1691-1704. doi: 10.1007/s00726-017-2466-6. Epub 2017 Jul 17.

PMID:
28718065
13.

Regulation of δ Opioid Receptor-Mediated Signaling and Antinociception in Peripheral Sensory Neurons by Arachidonic Acid-Dependent 12/15-Lipoxygenase Metabolites.

Sullivan LC, Chavera TA, Gao X, Pando MM, Berg KA.

J Pharmacol Exp Ther. 2017 Jul;362(1):200-209. doi: 10.1124/jpet.117.241604. Epub 2017 May 2. Erratum in: J Pharmacol Exp Ther. 2019 Apr;369(1):143.

14.

Studies To Examine Potential Tolerability Differences between the 5-HT2C Receptor Selective Agonists Lorcaserin and CP-809101.

Higgins GA, Silenieks LB, Patrick A, De Lannoy IAM, Fletcher PJ, Parker LA, MacLusky NJ, Sullivan LC, Chavera TA, Berg KA.

ACS Chem Neurosci. 2017 May 17;8(5):1074-1084. doi: 10.1021/acschemneuro.6b00444. Epub 2017 Mar 24.

PMID:
28338324
15.

Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.

Sullivan LC, Chavera TS, Jamshidi RJ, Berg KA, Clarke WP.

J Pharmacol Exp Ther. 2016 Dec;359(3):411-419. Epub 2016 Sep 22.

16.
17.

Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases.

Joosten SA, Sullivan LC, Ottenhoff TH.

J Immunol Res. 2016;2016:2695396. Epub 2016 Sep 6. Review.

18.

Recognition of the Major Histocompatibility Complex (MHC) Class Ib Molecule H2-Q10 by the Natural Killer Cell Receptor Ly49C.

Sullivan LC, Berry R, Sosnin N, Widjaja JM, Deuss FA, Balaji GR, LaGruta NL, Mirams M, Trapani JA, Rossjohn J, Brooks AG, Andrews DM.

J Biol Chem. 2016 Sep 2;291(36):18740-52. doi: 10.1074/jbc.M116.737130. Epub 2016 Jul 6.

19.

The Presence of HLA-E-Restricted, CMV-Specific CD8+ T Cells in the Blood of Lung Transplant Recipients Correlates with Chronic Allograft Rejection.

Sullivan LC, Westall GP, Widjaja JM, Mifsud NA, Nguyen TH, Meehan AC, Kotsimbos TC, Brooks AG.

PLoS One. 2015 Aug 24;10(8):e0135972. doi: 10.1371/journal.pone.0135972. eCollection 2015.

20.

Functional selectivity of kappa opioid receptor agonists in peripheral sensory neurons.

Jamshidi RJ, Jacobs BA, Sullivan LC, Chavera TA, Saylor RM, Prisinzano TE, Clarke WP, Berg KA.

J Pharmacol Exp Ther. 2015 Nov;355(2):174-82. doi: 10.1124/jpet.115.225896. Epub 2015 Aug 21.

21.

A bird's eye view of NK cell receptor interactions with their MHC class I ligands.

Saunders PM, Vivian JP, O'Connor GM, Sullivan LC, Pymm P, Rossjohn J, Brooks AG.

Immunol Rev. 2015 Sep;267(1):148-66. doi: 10.1111/imr.12319. Review.

PMID:
26284476
22.

Atypical antipsychotics and inverse agonism at 5-HT2 receptors.

Sullivan LC, Clarke WP, Berg KA.

Curr Pharm Des. 2015;21(26):3732-8.

23.

Dual regulation of δ-opioid receptor function by arachidonic acid metabolites in rat peripheral sensory neurons.

Sullivan LC, Berg KA, Clarke WP.

J Pharmacol Exp Ther. 2015 Apr;353(1):44-51. doi: 10.1124/jpet.114.221366. Epub 2015 Jan 30.

24.

Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.

Caccamo N, Pietra G, Sullivan LC, Brooks AG, Prezzemolo T, La Manna MP, Di Liberto D, Joosten SA, van Meijgaarden KE, Di Carlo P, Titone L, Moretta L, Mingari MC, Ottenhoff TH, Dieli F.

Eur J Immunol. 2015 Apr;45(4):1069-81. doi: 10.1002/eji.201445193. Epub 2015 Feb 17. Erratum in: Eur J Immunol. 2019 Jun;49(6):971.

25.

Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non-human primates.

Li J, Ahmet F, Sullivan LC, Brooks AG, Kent SJ, De Rose R, Salazar AM, Reis e Sousa C, Shortman K, Lahoud MH, Heath WR, Caminschi I.

Eur J Immunol. 2015 Mar;45(3):854-64. doi: 10.1002/eji.201445127. Epub 2015 Jan 14.

26.

Recognition of vitamin B metabolites by mucosal-associated invariant T cells.

Patel O, Kjer-Nielsen L, Le Nours J, Eckle SB, Birkinshaw R, Beddoe T, Corbett AJ, Liu L, Miles JJ, Meehan B, Reantragoon R, Sandoval-Romero ML, Sullivan LC, Brooks AG, Chen Z, Fairlie DP, McCluskey J, Rossjohn J.

Nat Commun. 2013;4:2142. doi: 10.1038/ncomms3142.

PMID:
23846752
27.

Signalling profile differences: paliperidone versus risperidone.

Clarke WP, Chavera TA, Silva M, Sullivan LC, Berg KA.

Br J Pharmacol. 2013 Oct;170(3):532-45. doi: 10.1111/bph.12295.

28.

Non-classical MHC Class I molecules regulating natural killer cell function.

Smyth MJ, Sullivan LC, Brooks AG, Andrews DM.

Oncoimmunology. 2013 Mar 1;2(3):e23336.

29.

HLA peptide length preferences control CD8+ T cell responses.

Rist MJ, Theodossis A, Croft NP, Neller MA, Welland A, Chen Z, Sullivan LC, Burrows JM, Miles JJ, Brennan RM, Gras S, Khanna R, Brooks AG, McCluskey J, Purcell AW, Rossjohn J, Burrows SR.

J Immunol. 2013 Jul 15;191(2):561-71. doi: 10.4049/jimmunol.1300292. Epub 2013 Jun 7.

30.

Targeting of a natural killer cell receptor family by a viral immunoevasin.

Berry R, Ng N, Saunders PM, Vivian JP, Lin J, Deuss FA, Corbett AJ, Forbes CA, Widjaja JM, Sullivan LC, McAlister AD, Perugini MA, Call MJ, Scalzo AA, Degli-Esposti MA, Coudert JD, Beddoe T, Brooks AG, Rossjohn J.

Nat Immunol. 2013 Jul;14(7):699-705. doi: 10.1038/ni.2605. Epub 2013 May 12.

PMID:
23666294
31.

Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells.

Heatley SL, Pietra G, Lin J, Widjaja JM, Harpur CM, Lester S, Rossjohn J, Szer J, Schwarer A, Bradstock K, Bardy PG, Mingari MC, Moretta L, Sullivan LC, Brooks AG.

J Biol Chem. 2013 Mar 22;288(12):8679-90. doi: 10.1074/jbc.M112.409672. Epub 2013 Jan 18.

32.

Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.

Andrews DM, Sullivan LC, Baschuk N, Chan CJ, Berry R, Cotterell CL, Lin J, Halse H, Watt SV, Poursine-Laurent J, Wang CR, Scalzo AA, Yokoyama WM, Rossjohn J, Brooks AG, Smyth MJ.

Nat Immunol. 2012 Dec;13(12):1171-7. doi: 10.1038/ni.2468. Epub 2012 Nov 11. Erratum in: Nat Immunol. 2013 Apr;14(4):413.

33.

DEC-205 is a cell surface receptor for CpG oligonucleotides.

Lahoud MH, Ahmet F, Zhang JG, Meuter S, Policheni AN, Kitsoulis S, Lee CN, O'Keeffe M, Sullivan LC, Brooks AG, Berry R, Rossjohn J, Mintern JD, Vega-Ramos J, Villadangos JA, Nicola NA, Nussenzweig MC, Stacey KJ, Shortman K, Heath WR, Caminschi I.

Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16270-5. doi: 10.1073/pnas.1208796109. Epub 2012 Sep 17.

34.

MHC class Ib-restricted CD8 T cells differ in dependence on CD4 T cell help and CD28 costimulation over the course of mouse polyomavirus infection.

Hofstetter AR, Ford ML, Sullivan LC, Wilson JJ, Hadley A, Brooks AG, Lukacher AE.

J Immunol. 2012 Apr 1;188(7):3071-9. doi: 10.4049/jimmunol.1103554. Epub 2012 Mar 5.

35.

A structural basis for antigen presentation by the MHC class Ib molecule, Qa-1b.

Zeng L, Sullivan LC, Vivian JP, Walpole NG, Harpur CM, Rossjohn J, Clements CS, Brooks AG.

J Immunol. 2012 Jan 1;188(1):302-10. doi: 10.4049/jimmunol.1102379. Epub 2011 Nov 30.

36.

Vβ2 natural killer T cell antigen receptor-mediated recognition of CD1d-glycolipid antigen.

Patel O, Pellicci DG, Uldrich AP, Sullivan LC, Bhati M, McKnight M, Richardson SK, Howell AR, Mallevaey T, Zhang J, Bedel R, Besra GS, Brooks AG, Kjer-Nielsen L, McCluskey J, Porcelli SA, Gapin L, Rossjohn J, Godfrey DI.

Proc Natl Acad Sci U S A. 2011 Nov 22;108(47):19007-12. doi: 10.1073/pnas.1109066108. Epub 2011 Nov 7.

37.

A semi-invariant Vα10+ T cell antigen receptor defines a population of natural killer T cells with distinct glycolipid antigen-recognition properties.

Uldrich AP, Patel O, Cameron G, Pellicci DG, Day EB, Sullivan LC, Kyparissoudis K, Kjer-Nielsen L, Vivian JP, Cao B, Brooks AG, Williams SJ, Illarionov P, Besra GS, Turner SJ, Porcelli SA, McCluskey J, Smyth MJ, Rossjohn J, Godfrey DI.

Nat Immunol. 2011 Jun 12;12(7):616-23. doi: 10.1038/ni.2051.

38.

A molecular basis for the exquisite CD1d-restricted antigen specificity and functional responses of natural killer T cells.

Wun KS, Cameron G, Patel O, Pang SS, Pellicci DG, Sullivan LC, Keshipeddy S, Young MH, Uldrich AP, Thakur MS, Richardson SK, Howell AR, Illarionov PA, Brooks AG, Besra GS, McCluskey J, Gapin L, Porcelli SA, Godfrey DI, Rossjohn J.

Immunity. 2011 Mar 25;34(3):327-39. doi: 10.1016/j.immuni.2011.02.001. Epub 2011 Mar 3.

39.

Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity.

Hofstetter AR, Sullivan LC, Lukacher AE, Brooks AG.

Curr Opin Immunol. 2011 Feb;23(1):104-10. doi: 10.1016/j.coi.2010.09.009. Epub 2010 Oct 21. Review.

40.

Allelic polymorphism in the T cell receptor and its impact on immune responses.

Gras S, Chen Z, Miles JJ, Liu YC, Bell MJ, Sullivan LC, Kjer-Nielsen L, Brennan RM, Burrows JM, Neller MA, Khanna R, Purcell AW, Brooks AG, McCluskey J, Rossjohn J, Burrows SR.

J Exp Med. 2010 Jul 5;207(7):1555-67. doi: 10.1084/jem.20100603. Epub 2010 Jun 21.

41.

Cross-presentation of HCMV chimeric protein enables generation and measurement of polyclonal T cells.

Nguyen TH, Sullivan LC, Kotsimbos TC, Schwarer AP, Mifsud NA.

Immunol Cell Biol. 2010 Aug;88(6):676-84. doi: 10.1038/icb.2010.20. Epub 2010 Mar 2.

PMID:
20195281
42.

Vitamin E status and metabolism in adult and aged aryl hydrocarbon receptor null mice.

Traber MG, Mustacich DJ, Sullivan LC, Leonard SW, Ahern-Rindell A, Kerkvliet N.

J Nutr Biochem. 2010 Dec;21(12):1193-9. doi: 10.1016/j.jnutbio.2009.10.005. Epub 2010 Feb 12.

43.

Natural killer cell activation in the lung allograft early posttransplantation.

Meehan AC, Sullivan LC, Mifsud NA, Brooks AG, Snell GI, Kotsimbos TC, Westall GP.

Transplantation. 2010 Mar 27;89(6):756-63. doi: 10.1097/TP.0b013e3181cab17f.

PMID:
20019647
44.

Differential recognition of CD1d-alpha-galactosyl ceramide by the V beta 8.2 and V beta 7 semi-invariant NKT T cell receptors.

Pellicci DG, Patel O, Kjer-Nielsen L, Pang SS, Sullivan LC, Kyparissoudis K, Brooks AG, Reid HH, Gras S, Lucet IS, Koh R, Smyth MJ, Mallevaey T, Matsuda JL, Gapin L, McCluskey J, Godfrey DI, Rossjohn J.

Immunity. 2009 Jul 17;31(1):47-59. doi: 10.1016/j.immuni.2009.04.018.

45.

The shaping of T cell receptor recognition by self-tolerance.

Gras S, Burrows SR, Kjer-Nielsen L, Clements CS, Liu YC, Sullivan LC, Bell MJ, Brooks AG, Purcell AW, McCluskey J, Rossjohn J.

Immunity. 2009 Feb 20;30(2):193-203. doi: 10.1016/j.immuni.2008.11.011. Epub 2009 Jan 22.

46.

The major histocompatibility complex class Ib molecule HLA-E at the interface between innate and adaptive immunity.

Sullivan LC, Clements CS, Rossjohn J, Brooks AG.

Tissue Antigens. 2008 Nov;72(5):415-24. doi: 10.1111/j.1399-0039.2008.01138.x. Review.

PMID:
18946929
47.

Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors.

Hoare HL, Sullivan LC, Clements CS, Ely LK, Beddoe T, Henderson KN, Lin J, Reid HH, Brooks AG, Rossjohn J.

J Mol Biol. 2008 Apr 11;377(5):1297-303. doi: 10.1016/j.jmb.2008.01.098. Epub 2008 Feb 12. Review.

PMID:
18339401
48.

CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.

Petrie EJ, Clements CS, Lin J, Sullivan LC, Johnson D, Huyton T, Heroux A, Hoare HL, Beddoe T, Reid HH, Wilce MC, Brooks AG, Rossjohn J.

J Exp Med. 2008 Mar 17;205(3):725-35. doi: 10.1084/jem.20072525. Epub 2008 Mar 10.

49.

The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition.

Sullivan LC, Clements CS, Beddoe T, Johnson D, Hoare HL, Lin J, Huyton T, Hopkins EJ, Reid HH, Wilce MC, Kabat J, Borrego F, Coligan JE, Rossjohn J, Brooks AG.

Immunity. 2007 Dec;27(6):900-11.

50.

A structural perspective on MHC class Ib molecules in adaptive immunity.

Sullivan LC, Hoare HL, McCluskey J, Rossjohn J, Brooks AG.

Trends Immunol. 2006 Sep;27(9):413-20. Epub 2006 Jul 21. Review.

PMID:
16860610

Supplemental Content

Loading ...
Support Center